Should we optimise or revise the management of initially unresectable stage III non-small cell lung cancer: rethinking consolidation therapy

Journal of the National Cancer Center · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles